InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Aslan Fred. Officer active across 1 company, notably Artiva Biotherapeutics, Inc.. Cumulatively, 8 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €147k. History available since 22 July 2024. The latest transaction was disclosed on 15 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Aslan Fred is a declarant linked to Artiva Biotherapeutics, Inc., where the listed role is President and CEO. Across 8 filings in total, the 8 sampled filings from 2024-07-22 to 2026-02-18 show EUR 0 of buys and EUR 147065 of sells, with the modal transaction nature listed as Attribution.